María Antonietta Barbieri

Author

Also Known As

Antonio Gatto, M A Barbieri, M Barbieri, M. A. Barbieri, M. Barbieri, M.A. Barbieri, MARIA BARBIERI, Maria A. Barbieri, Maria Antonietta Barbieri, Maria Barbieri

101

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

University of Messina Bambino Gesù Children's Hospital Istituti di Ricovero e Cura a Carattere Scientifico Istituto Ortopedico Gaetano Pini Hamilton Health Sciences

About

María Antonietta Barbieri is an author at University of Messina specializing in medicine, pharmacotherapy, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	5.2K
2	Public Health	4	4	2.9K
3	Health Sciences	1	1	10
4	Allergy	1	1	10
5	Biology	1	1	10

María Antonietta Barbieri

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Sonia S. Anand, Jackie Bosch, John W. Eikelboom, The Lancet ThrombosisCardiovascular DiseaseStrokeMedicinePlacebo-controlled Trial	2017	855
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, The Lancet ThrombosisCardiovascular DiseaseAtherosclerosisMedicineCoronary Artery Disease	2017	749
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Characteristic of COVID-19 infection in pediatric patients: early findings from two Italian Pediatric Research Networks Niccolò Parri, Anna Maria Magistà, Federico Marchetti, European Journal of Pediatrics	2020	160
COVID-19 in 17 Italian Pediatric Emergency Departments Niccolò Parri, Matteo Lenge, Barbara Cantoni, PEDIATRICS	2020	98
Impact of the COVID-19 pandemic on the Emergency Department of a tertiary children’s hospital Umberto Raucci, Anna Maria Musolino, Domenico Di Lallo, The Italian Journal of Pediatrics/Italian journal of pediatrics	2021	75
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy Roberta Roberti, Luigi Francesco Iannone, Caterina Palleria, Current Medical Research and Opinion	2020	50
Prognostic value of extravascular lung water index in critically ill children with acute respiratory failure Riccardo Lubrano, Corrado Cecchetti, M. Elli, Intensive Care Medicine Acute Lung InjuryIll ChildrenCritical Care MedicineAcute Respiratory FailurePrognostic Value	2010	42
Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database María Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Frontiers in Pharmacology	2019	37

Page 1